The changes in health-related quality of life in stable coronary artery disease patients and intermediante coronary lesions after elective percutaneous coronary intervention
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Main Article Content
https://orcid.org/0000-0001-9741-9075
Abstract
The aim – to analyze the factors, associated with the change in health-related quality of life (HRQoL) in stable coronary artery disease (SCAD) patients with intermediate coronary lesions at 3-months follow-up after elective percutaneous coronary intervention (PCI).
Materials and methods. A prospective single-center study enrolled 84 SCAD patients (mean age 64±8 years; males – 73 %) with intermediate coronary lesions (stenosis 50-90 %) (by invasive coronary angiography [ICA]), consecutively enrolled and hospitalized with the aim of elective PCI to be performed. HRQoL was evaluated by SF-36 (physical health summary [PHsum] and mental health summary [МНsum]) and SAQ (Seattle Angina Questionnaire»; the domains «physical limitation» [PL], «angina stability» [AS], «angina frequency» [AF], «treatment satisfaction» [TS] and «disease perception» [DP]), – at baseline and 3-months follow-up. The enrolled sample was subdivided in a dichotomous manner into the HRQoL «improvement» or «non-improvement» patterns, based on the cut-off-values (COVs) of clinically meaningful change of the certain HRQoL parameter score at 3-months follow-up after PCI.
Results and discussion. We revealed an improvement of average (median) HRQoL parameters at 3-months follow-up after PCI, namely PHsum (score increase from 38.8 to 43.1; р < 0.001), SAQ-AS (25 to 75; р < 0.001), SAQ-AF (70 to 80; р < 0.001), SAQ-TS (58.8 to 70.6; р < 0.001) and SAQ-DP (45.8 to 66.7; р < 0.001). The clinically meaningful HRQoL improvement ranged from 14 % to 71 % cases, depending on the certain HRQoL parameter and the COVs of its change at follow-up after PCI. The worse baseline HRQoL, older age and higher baseline total cholesterol level were the factors, associated with the increased probability of HRQoL to be meaningfully improved after revascularization. In addition, a presence of diabetes mellitus, a history of acute cerebrovascular accident, and the ICA data on multivessel disease and in-stent restenosis after previous PCI, – all were associated with the lower odds of HRQoL «improvement» status to be achieved.
Conclusions. A PCI favored the HRQoL improvement in SCAD patients at 3-months follow-up. The clinical and angiographic factors, associated with the post-procedure change in HRQoL, should be considered for a better selection of SCAD patients with intermediate coronary lesions for PCI.
Article Details
Keywords:
References
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41(3):407-77. https://doi.org/10.1093/eurheartj/ehz425.
Writing Committee Members; Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Aug 29;82(9):833-955. https://doi.org/10.1016/j.jacc.2023.04.003.
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. https://doi.org/10.1093/eurheartj/ehy394.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e4-e17. https://doi.org/10.1161/CIR.0000000000001039.
Rubino F, Pompei G, Brugaletta S, Collet C, Kunadian V. The role of physiology in the contemporary management of coronary artery disease. Heart. 2024 Feb 23;110(6):391-8. https://doi.org/10.1136/heartjnl-2023-322641.
Sanz Sánchez J, Farjat Pasos JI, Martinez Solé J, Hussain B, Kumar S, Garg M, Chiarito M, Teira Calderón A, Sorolla-Romero JA, Echavarria Pinto M, Shin ES, Diez Gil JL, Waksman R, van de Hoef TP, Garcia-Garcia HM. Fractional flow reserve use in coronary artery revascularization: A systematic review and meta-analysis. iScience. 2023 Jul 3;26(8):107245. https://doi.org/10.1016/j.isci.2023.107245.
Tsoulou V, Vasilopoulos G, Kapadochos T, Pavlatou N, Kalogianni A, Toulia G, Dousis E, Panoutsopoulos G, Kourakos M, Polikandrioti M. Quality of Life in Patients Undergoing Percutaneous Coronary Intervention. Clin Pract. 2023 May 17;13(3):621-37. https://doi.org/10.3390/clinpract13030057.
da Silveira LMV, Almeida AS, Fuchs FC, Silva AG, Lucca MB, Scopel S, Fuchs SC, Fuchs FD. Quality of life in patients with stable coronary artery disease submitted to percutaneous, surgical, and medical therapies: a cohort study. Health Qual Life Outcomes. 2021 Nov 24;19(1):261. https://doi.org/10.1186/s12955-021-01886-7.
Spertus JA, Jones PG, Maron DJ, O’Brien SM, Reynolds HR, Rosenberg Y, Stone GW, Harrell FE Jr, Boden WE, Weintraub WS, Baloch K, Mavromatis K, Diaz A, Gosselin G, Newman JD, Mavromichalis S, Alexander KP, Cohen DJ, Bangalore S, Hochman JS, Mark DB; ISCHEMIA Research Group. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med. 2020 Apr 9;382(15):1408-19. https://doi.org/10.1056/NEJMoa1916370.
Siriyotha S, Pattanaprateep O, Srimahachota S, Sansanayudh N, Thakkinstian A, Limpijankit T. Factors associated with health-related quality of life in patients undergoing percutaneous coronary intervention: Thai PCI registry. Front Cardiovasc Med. 2023 Nov 8;10:1260993. https://doi.org/10.3389/fcvm.2023.1260993.
Elbadawi A, Sedhom R, Ghoweba M, Etewa AM, Kayani W, Rahman F. Contemporary Use of Coronary Physiology in Cardiology. Cardiol Ther. 2023 Dec;12(4):589-614. https://doi.org/10.1007/s40119-023-00329-2.
Stan MV, Mikhaliev KO, Khokhlov AV, Zharinov OJ, Todurov BM. Clinical and hemodynamic characteristics of patients with intermediate coronary lesions selected for elective percutaneous coronary intervention. Kardiokhirurhiia ta Interventsiina Kardiolohiia [Cardiac Surgery and Interventional Cardiology]. 2023;1-2(38-39):41-52. http://doi.org/10.31928/2305-3127-2023.1-2.2940. Ukrainian.
Stan MV, Mikhaliev KO, Zharinov OJ, Khokhlov AV, Todurov BM. Clinical, angiographic and functional parameters determining decision to perform revascularization in stable coronary artery disease patients with intermediate coronary lesions. Clin Prev Med. 2023;8(30):15-29. https://doi.org/10.31612/2616-4868.8.2023.02.
Ware J, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Boston, MA: The Health Institute, New England Medical Center Hospitals, 1994. 190 p.
Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995 Feb;25(2):333-41. https://doi.org/10.1016/0735-1097(94)00397-9.
Thomas M, Jones PG, Arnold SV, Spertus JA. Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care: A Review. JAMA Cardiol. 2021 May 1;6(5):593-9. https://doi.org/10.1001/jamacardio.2020.7478.
Collet C, Collison D, Mizukami T, McCartney P, Sonck J, Ford T, Munhoz D, Berry C, De Bruyne B, Oldroyd K. Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease. JACC Cardiovasc Interv. 2022 Dec 26;15(24):2506-18. https://doi.org/10.1016/j.jcin.2022.09.048.
Bishawi M, Hattler B, Almassi GH, Spertus JA, Quin JA, Collins JF, Grover FL, Shroyer AL; VA #517 Randomized On/Off Bypass (ROOBY) Study Group. Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial. Am Heart J. 2018 Apr;198:33-8. https://doi.org/10.1016/j.ahj.2017.12.014.
Wijeysundera HC, Qiu F, Fefer P, Bennell MC, Austin PC, Ko DT. Association between appropriateness of coronary revascularization and quality of life in patients with stable ischemic heart disease. BMC Cardiovasc Disord. 2014 Oct 4;14:137. https://doi.org/10.1186/1471-2261-14-137.
Wyrwich KW, Spertus JA, Kroenke K, Tierney WM, Babu AN, Wolinsky FD; Heart Disease Expert Panel. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J. 2004 Apr;147(4):615-22. https://doi.org/10.1016/j.ahj.2003.10.039.
Rumsfeld JS, Alexander KP, Goff DC Jr, Graham MM, Ho PM, Masoudi FA, Moser DK, Roger VL, Slaughter MS, Smolderen KG, Spertus JA, Sullivan MD, Treat-Jacobson D, Zerwic JJ; American Heart Association Council on Quality of Care and Outcomes Research, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Stroke Council. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation. 2013 Jun 4;127(22):2233-49. https://doi.org/10.1161/CIR.0b013e3182949a2e.
Hirao Y, Seki T, Watanabe N, Matoba S. Health-Related Quality of Life After Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: A Systematic Review and Meta-analysis. Can J Cardiol. 2023 Nov;39(11):1539-48. doi: 10.1016/j.cjca.2023.06.429.
Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O’Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group; Mancini GB. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008 Aug 14;359(7):677-87. https://doi.org/10.1056/NEJMoa072771.
Nowbar AN, Francis DP, Al-Lamee RK. Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding. Cardiovasc Drugs Ther. 2022 Oct;36(5):1011-8. https://doi.org/10.1007/s10557-021-07198-8.
Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Nowbar AN, Simader FA, Davies JR, O’Kane PD, Haworth P, Routledge H, Kotecha T, Gamma R, Clesham G, Williams R, Din J, Nijjer SS, Curzen N, Ruparelia N, Sinha M, Dungu JN, Ganesananthan S, Khamis R, Mughal L, Kinnaird T, Petraco R, Spratt JC, Sen S, Sehmi J, Collier DJ, Sohaib A, Keeble TR, Cole GD, Howard JP, Francis DP, Shun-Shin MJ, Al-Lamee RK; ORBITA-2 Investigators. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina. N Engl J Med. 2023 Dec 21;389(25):2319-30. https://doi.org/10.1056/NEJMoa2310610.
Conradie A, Atherton J, Chowdhury E, Duong M, Schwarz N, Worthley S, Eccleston D. Health-Related Quality of Life (HRQoL) and the Effect on Outcome in Patients Presenting with Coronary Artery Disease and Treated with Percutaneous Coronary Intervention (PCI): Differences Noted by Sex and Age. J Clin Med. 2022 Sep 5;11(17):5231. https://doi.org/10.3390/jcm11175231.
Stan MV, Mikhaliev КО, Zharinov OJ, Khokhlov AV, Kravchenko AM, Todurov BM. Association of fractional flow reserve with clinical and angiographic characteristics of patients with stable coronary artery disease. Wiad Lek. 2022;75(11 pt 1):2665-70. doi: 10.36740/WLek202211120.
Barbato E, Toth GG, Johnson NP, Pijls NH, Fearon WF, Tonino PA, Curzen N, Piroth Z, Rioufol G, Jüni P, De Bruyne B. A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve. J Am Coll Cardiol. 2016 Nov 29;68(21):2247-55. https://doi.org/10.1016/j.jacc.2016.08.055.
Devereux N, Berns AM. Evaluation & Treatment of Psychological Effects of Stroke. Dela J Public Health. 2023 Aug 31;9(3):62-69. https://doi.org/10.32481/djph.2023.08.011.
Snoek FJ. Mental health in diabetes care. Time to step up. Front Clin Diabetes Healthc. 2022 Oct 13;3:1039192. https://doi.org/10.3389/fcdhc.2022.1039192.
Vulcănescu D, Gheorman V, Pîrvu DC, Dinescu VC, Gheorman V, Udriștoiu I, Paraschiv AM, Bunescu MG, Berceanu MC, Gheorman L, Dinescu SN, Popa R, Florescu C, Mită A, Forțofoiu CM. Primary PCI and Mental Health: A 12-Month Follow-Up Study. Healthcare (Basel). 2023 Jun 1;11(11):1620. https://doi.org/10.3390/healthcare11111620.
Collison D, Copt S, Mizukami T, Collet C, McLaren R, Didagelos M, Aetesam-Ur-Rahman M, McCartney P, Ford TJ, Lindsay M, Shaukat A, Rocchiccioli P, Brogan R, Watkins S, McEntegart M, Good R, Robertson K, O’Boyle P, Davie A, Khan A, Hood S, Eteiba H, Berry C, Oldroyd KG. Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors. Circ Cardiovasc Interv. 2023 Apr;16(4):e012511. https://doi.org/10.1161/CIRCINTERVENTIONS.122.012511.
Hennigan B, Berry C, Collison D, Corcoran D, Eteiba H, Good R, McEntegart M, Watkins S, McClure JD, Mangion K, Ford TJ, Petrie MC, Hood S, Rocchiccioli P, Shaukat A, Lindsay M, Oldroyd KG. Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial. Heart. 2020 May;106(10):758-64. https://doi.org/10.1136/heartjnl-2019-316075.